Login | Register Shopping Cart (Login required) PRODUCTS AND SERVICES NEWS Q&A VIDEOS CAREERS ABOUT INVESTOR RELATIONS BLOGS CONTACT Corporate Governance Press Releases Financial Reports Annual Reports Financial Calendar Subscribe Home Investor Relations Press Releases På svenska Investerarrelationer svenska » Press Releases Language English Svenska Year 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Mon, 16 Jul 2018 09:00:00 +0200 Interim report January - June 2018 Wed, 09 May 2018 12:00:00 +0200 Biotage and CEO Torben Jörgensen have agreed to extend period of service Fri, 27 Apr 2018 06:30:00 +0200 Resolutions at the Annual General Meeting in Biotage AB on April 26, 2018 Thu, 26 Apr 2018 13:00:00 +0200 Interim report January - March 2018 Tue, 27 Mar 2018 06:30:00 +0200 NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ) Tue, 27 Mar 2018 06:30:00 +0200 Biotage AB (publ) publishes its 2017 Annual Report and Corporate Governance Report Mon, 05 Mar 2018 07:30:00 +0100 Biotage AB –Nomination Committee proposal for the election of Board of Directors and Chairman of the Board Thu, 08 Feb 2018 07:30:00 +0100 Year-end report January - December 2017 High growth rate and significantly improved result Tue, 16 Jan 2018 16:00:00 +0100 Closing of Biotage’s acquisition of Horizon Technology Wed, 06 Dec 2017 15:00:00 +0100 Biotage acquires Horizon Technology and strengthens its position in environmental and food safety Thu, 02 Nov 2017 07:30:00 +0100 Interim report January - September 2017 Wed, 16 Aug 2017 09:00:00 +0200 Biotage – alleged patent infringement settled - correction Wed, 16 Aug 2017 06:30:00 +0200 Biotage – alleged patent infringement settled Tue, 18 Jul 2017 09:00:00 +0200 Interim report January - June 2017 Fri, 28 Apr 2017 06:30:00 +0200 Resolutions at the Annual General Meeting in Biotage AB on April 27, 2017 Fri, 28 Apr 2017 06:30:00 +0200 Biotage AB launches share buy-back The board of directors of Biotage AB (publ) has resolved to start a share buy-back program in accordance with the Annual General Meeting’s resolution to authorize the board to decide on the acquisition and sale of the company’s own shares. Thu, 27 Apr 2017 13:00:00 +0200 Interim report January-March 2017 Good growth and substantially improved operating profit Thu, 06 Apr 2017 06:30:00 +0200 Biotage AB (publ) publishes its 2016 Annual Report and Corporate Governance Report and Financial Goals for the period 2017 – 2019 Tue, 28 Mar 2017 06:30:00 +0200 NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ) Thu, 02 Mar 2017 12:50:00 +0100 Proposal by the Nomination Committee regarding the Board of Directors of Biotage AB – Yvonne Mårtensson is proposed as new director Thu, 09 Feb 2017 07:30:00 +0100 Year-end report January-December 2016 Mon, 02 Jan 2017 08:46:00 +0100 Biotage’s shares now traded on the Mid Cap segment of Nasdaq OMX Nordic About Biotage Biotage is a global Life Science company that develops innovative and effective solutions for separation within organic and analytical chemistry, as well as for industrial applications. Biotage is listed on NASDAQ Stockholm. Legal Terms | Sitemap | Send Feedback LinkedIn Twitter Facebook Google+ Vimeo YouTube